⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

CABA News

Cabaletta Bio, Inc. Common Stock

Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress